Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket

Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) rose sharply in today's pre-market trading after the company announced expanded US FDA approval of ELEVIDYS to Duchenne Muscular Dystrophy patients a

BenzingaJun 21 08:22 ET

Lion Group Unveils 2024 Share Incentive Plan

TipRanksMay 24 17:57 ET

6-K: Report of foreign private issuer (related to financial reporting)

SEC announcementMay 24 17:04 ET · Announcements

Lion Group Loses Roar After Trumpeting GPT-4o Links

Baystreet.caMay 23 09:48 ET

Express News | Lion Group Holding Plans To Use GPT-4o To 'Enhance' Products

BenzingaMay 23 08:32 ET

Express News | Lion Group Holding Plans to Use Gpt-4O to Enhance Products and Services

ReutersMay 23 08:31 ET